Please sign in to follow a disease.
Congenital lobar emphysema
MONDO:0007536Congenital lobar emphysema (CLE) is a respiratory abnormality characterized by respiratory distress due to hyperinflation of one or more affected lobes of the lung.
Also known as: CLE, Emphysema, Congenital Lobar, congenital lobar hyperinflation, emphysema, congenital lobar, infantile lobar hyperinflation
15 clinical trials for this condition and its sub-types, 2 tagged with Congenital lobar emphysema itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
New antibody drug takes aim at autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new drug called SAR448501 (DR-0201) in 62 adults with lupus or rheumatoid arthritis. The drug is a bispecific antibody designed to target the immune system. The main goal is to check safety and find the right dose, not yet to prove it works. Partici…
Phase 1 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New pill VENT-03 aims to calm lupus skin flares
Disease control Recruiting nowThis study tests an experimental tablet called VENT-03 for people with active cutaneous lupus erythematosus (CLE), a condition causing painful skin rashes. Twenty-four adults will take either VENT-03 or a placebo for 4 weeks, then everyone gets VENT-03 for 8 more weeks. Researche…
Phase 2 • Sponsor: Ventus Therapeutics U.S., Inc. • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC